-
Continuous Subcutaneous Administration of Levodopa/Carbidopa (ND0612) for the Treatment of Parkinson's Disease
… and activity of daily living, quality of life, quality of sleep and “on-off” periods during visit days. Oral levodopa … 0.4h and 1.4h with placebo). ND0612L improved quality of sleep by 30% compared to 1% in the placebo group, expressed …
-
John A. Gruner, PhD
… of action analgesic agents; and actions of drugs on sleep and wake activity. He was a critical discovery team …
-
Christopher Winrow, PhD
… Parkinson’s disease, Alzheimer’s disease, dementia, sleep disorders, autism and mitochondrial diseases. Dr. …
-
Getting Ready for the International Congress of Parkinson's Disease and Movement Disorders
September 20, 2019
… p.m., Teaching Course 3309. Recognition and Management of Sleep Disturbances in Movement Disorders. Ron Postuma et al …
-
Five Clinical Studies to Receive $2.5 Million Under Foundation’s 2007 Clinical Discovery Program
December 4, 2007
… that are a side effect of long-term levodopa treatment), sleep disorders and excessive salivation. “The Michael J. … , MD, of the University of Michigan will focus on improving sleep disorders, a common problem in Parkinson’s. Dr. Albin … investigate the role of serotonin neurons in PD-related sleep-disordered breathing. He will visualize serotonin …
-
A Privilege to Participate
October 17, 2019
… feels distressed by symptoms that occur while she is sleeping. “I’ve heard them referred to as ‘acting out of … those movements, which is very disruptive to my husband’s sleep. And if I’m having a nightmare that someone is …